Pulmonx Corp reports results for the quarter ended in March - Earnings Summary

Pulmonx

02/05/2023 23:02

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 42
cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 44 cents per share.
    * Revenue rose 34.8% to $14.54 million from a year ago;
analysts
expected $13.49 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 42
cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had risen by 10.2% this quarter and
gained 46.1% so far this year.
    * The company reported a quarterly loss of $15.86 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 10:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.44          -0.42          Beat
 Dec. 31 2022      -0.42          -0.38          Beat
 Sep. 30 2022      -0.40          -0.38          Beat
 Jun. 30 2022      -0.41          -0.40          Beat